Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP314861.RA4oEMdNfFjNoIHEgXEsFb20pAmPqcon5gTovObe_WW4Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP314861.RA4oEMdNfFjNoIHEgXEsFb20pAmPqcon5gTovObe_WW4Y130_assertion type Assertion NP314861.RA4oEMdNfFjNoIHEgXEsFb20pAmPqcon5gTovObe_WW4Y130_head.
- NP314861.RA4oEMdNfFjNoIHEgXEsFb20pAmPqcon5gTovObe_WW4Y130_assertion description "[IR-A is often aberrantly expressed in cancer cells, thus increasing their responsiveness to IGF-II and to insulin and explaining the cancer-promoting effect of hyperinsulinemia observed in obese and type 2 diabetic patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP314861.RA4oEMdNfFjNoIHEgXEsFb20pAmPqcon5gTovObe_WW4Y130_provenance.
- NP314861.RA4oEMdNfFjNoIHEgXEsFb20pAmPqcon5gTovObe_WW4Y130_assertion evidence source_evidence_literature NP314861.RA4oEMdNfFjNoIHEgXEsFb20pAmPqcon5gTovObe_WW4Y130_provenance.
- NP314861.RA4oEMdNfFjNoIHEgXEsFb20pAmPqcon5gTovObe_WW4Y130_assertion SIO_000772 19752219 NP314861.RA4oEMdNfFjNoIHEgXEsFb20pAmPqcon5gTovObe_WW4Y130_provenance.
- NP314861.RA4oEMdNfFjNoIHEgXEsFb20pAmPqcon5gTovObe_WW4Y130_assertion wasDerivedFrom befree-20140225 NP314861.RA4oEMdNfFjNoIHEgXEsFb20pAmPqcon5gTovObe_WW4Y130_provenance.
- NP314861.RA4oEMdNfFjNoIHEgXEsFb20pAmPqcon5gTovObe_WW4Y130_assertion wasGeneratedBy ECO_0000203 NP314861.RA4oEMdNfFjNoIHEgXEsFb20pAmPqcon5gTovObe_WW4Y130_provenance.